BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31984449)

  • 1. Comorbidity and stage at diagnosis among lung cancer patients in the US military health system.
    Lin J; McGlynn KA; Nations JA; Shriver CD; Zhu K
    Cancer Causes Control; 2020 Mar; 31(3):255-261. PubMed ID: 31984449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancer.
    Ahn DH; Mehta N; Yorio JT; Xie Y; Yan J; Gerber DE
    Clin Lung Cancer; 2013 Nov; 14(6):644-50. PubMed ID: 23886797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Preexisting Mental Health Disorders on the Diagnosis, Treatment, and Survival among Lung Cancer Patients in the U.S. Military Health System.
    Lin J; McGlynn KA; Carter CA; Nations JA; Anderson WF; Shriver CD; Zhu K
    Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1564-1571. PubMed ID: 27566418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin use and survival after non-small cell lung cancer: A cohort study in the US Military health system.
    Lin J; Gill A; Zahm SH; Carter CA; Shriver CD; Nations JA; Anderson WF; McGlynn KA; Zhu K
    Int J Cancer; 2017 Jul; 141(2):254-263. PubMed ID: 28380674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
    Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
    Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between age, deprivation and specific comorbid conditions and the receipt of major surgery in patients with non-small cell lung cancer in England: A population-based study.
    Belot A; Fowler H; Njagi EN; Luque-Fernandez MA; Maringe C; Magadi W; Exarchakou A; Quaresma M; Turculet A; Peake MD; Navani N; Rachet B
    Thorax; 2019 Jan; 74(1):51-59. PubMed ID: 30100577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma.
    Huang JY; Jian ZH; Ndi Nfor O; Jhang KM; Ku WY; Ko PC; Jan SR; Ho CC; Lung CC; Pan HH; Liang YC; Liaw YP
    PLoS One; 2015; 10(7):e0133367. PubMed ID: 26196516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic obstructive lung diseases and risk of non-small cell lung cancer in women.
    Schwartz AG; Cote ML; Wenzlaff AS; Van Dyke A; Chen W; Ruckdeschel JC; Gadgeel S; Soubani AO
    J Thorac Oncol; 2009 Mar; 4(3):291-9. PubMed ID: 19190518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunotherapy Utilization Among Patients With Metastatic NSCLC: Impact of Comorbidities.
    Zhang D; Tailor TD; Kim C; Atkins MB; Braithwaite D; Akinyemiju T
    J Immunother; 2021 Jun; 44(5):198-203. PubMed ID: 33758148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Trends in the Distribution of Lung Cancer Stage at Diagnosis in the Department of Defense Cancer Registry and the Surveillance, Epidemiology, and End Results data, 1989-2012.
    Nations JA; Brown DW; Shao S; Shriver CD; Zhu K
    Mil Med; 2020 Dec; 185(11-12):e2044-e2048. PubMed ID: 32857164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic obstructive pulmonary disease and comorbidities' influence on mortality in non-small cell lung cancer patients.
    Media AS; Persson M; Tajhizi N; Weinreich UM
    Acta Oncol; 2019 Aug; 58(8):1102-1106. PubMed ID: 31092081
    [No Abstract]   [Full Text] [Related]  

  • 14. Distance from accessible specialist care and other determinants of advanced or unknown stage at diagnosis of people with non-small cell lung cancer: A data linkage study.
    Tracey E; McCaughan B; Badgery-Parker T; Young J; Armstrong B
    Lung Cancer; 2015 Oct; 90(1):15-21. PubMed ID: 26275475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What are the clinical symptoms and physical signs for non-small cell lung cancer before diagnosis is made? A nation-wide multicenter 10-year retrospective study in China.
    Xing PY; Zhu YX; Wang L; Hui ZG; Liu SM; Ren JS; Zhang Y; Song Y; Liu CC; Huang YC; Liao XZ; Xing XJ; Wang DB; Yang L; Du LB; Liu YQ; Zhang YZ; Liu YY; Wei DH; Zhang K; Shi JF; Qiao YL; Chen WQ; Li JL; Dai M;
    Cancer Med; 2019 Jul; 8(8):4055-4069. PubMed ID: 31150167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of multimorbidity in short-term mortality of lung cancer patients in Spain: a population-based cohort study.
    Niksic M; Redondo-Sanchez D; Chang YL; Rodriguez-Barranco M; Exposito-Hernandez J; Marcos-Gragera R; Oliva-Poch E; Bosch-Barrera J; Sanchez MJ; Luque-Fernandez MA
    BMC Cancer; 2021 Sep; 21(1):1048. PubMed ID: 34556072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidity in older surgical cancer patients: influence on patient care and outcome.
    Janssen-Heijnen ML; Maas HA; Houterman S; Lemmens VE; Rutten HJ; Coebergh JW
    Eur J Cancer; 2007 Oct; 43(15):2179-93. PubMed ID: 17681780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of comorbidity in the management and prognosis in nonsmall cell lung cancer: a population-based study.
    Nilsson J; Berglund A; Bergström S; Bergqvist M; Lambe M
    Acta Oncol; 2017 Jul; 56(7):949-956. PubMed ID: 28486004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stage at diagnosis: Comparison of insurance status in SEER to the Department of Defense Cancer Registry.
    Flanary JT; Lin J; Shriver CD; Zhu K
    Cancer Med; 2023 Nov; 12(22):20989-21000. PubMed ID: 37902129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer stage at diagnosis: Individual associations in the prospective VITamins and lifestyle (VITAL) cohort.
    Slatore CG; Gould MK; Au DH; Deffebach ME; White E
    BMC Cancer; 2011 Jun; 11():228. PubMed ID: 21649915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.